Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|September 24, 2020
CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinomaPeter Makhov, Ji A Sohn, Ilya G Serebriiskii, et al.
International Journal of Oncology|April 21, 2022
Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)Marsel Khabibov, Airat Garifullin, Yanis Boumber, et al.
Research Square|April 25, 2024
Musashi-2 (MSI2) regulation of DNA damage response in lung cancerIgor Bychkov, Alexander Deneka, Iuliia Topchu, et al.
Plos One|July 8, 2021
Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progressionLeonid Kharin, Igor Bychkov, Nikolay Karnaukhov, et al.
Cellular and Molecular Life Sciences : CMLS|May 9, 2022
The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumorsIuliia Topchu, Rajendra P Pangeni, Igor Bychkov, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Musashi-2 (MSI2) regulation of DNA damage response in lung cancerIgor Bychkov, Alexander Deneka, Iuliia Topchu, et al.
Cancer Research|December 7, 2007
Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panelLanlan Shen, Yutaka Kondo, Saira Ahmed, et al.
Plos One|May 3, 2013
Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemiaShao-Qing Kuang, Zhihong Fang, Patrick A Zweidler-McKay, et al.
BMC Cancer|June 26, 2019
An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusionTim N Beck, Alexander Y Deneka, Louis Chai, et al.
Clinical Lung Cancer|September 14, 2025
DISCERN: A Randomized Pilot Study Comparing Dual Versus Single Immune Checkpoint Blockade Plus Chemotherapy in PD-L1 Negative Advanced Non-Small Cell Lung CancerAakash Desai, Ellen McNeeley, Sanad Alhushki, et al.
Pageof 6